P&G urges diphenhydramine/dextromethorphan combo use as antihistamine/antitussive.
This article was originally published in The Tan Sheet
Executive Summary
DIPHENHYDRAMINE/DEXTROMETHORPHAN COMBO AS ANTIHISTAMINE/ANTITUSSIVE should be permitted if the diphenhydramine com-ponent is kept to the lowest recommended dose, Procter & Gamble urged in May 9 comments to FDA. P&G advised that "a combination of diphenhydramine and dextromethorphan be permitted when the lowest dosage level of diphenhydramine is used for the antihistamine indication and...dextromethorphan [is] maintained as the antitussive component."
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning